MAPT and frontotemporal dementia: Multicentre replication with larger samples and broader diagnostic spectra are necessary, including for example, patients with frontotemporal dementia, corticobasal syndrome, or presymptomatic individuals with high risk of developing tau-related neurodegenerative disorders (e.g. carrying specific gene mutations).